# GENOCEA BIOSCIENCES, INC.

GENOCEA BIOSCIENCES, INC. is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** GENOCEA BIOSCIENCES, INC.
- **Former names in filing history:** GENOCEA BIOSCIENCES INC (2009-02-25 to 2009-02-25)
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001457612

## About

GENOCEA BIOSCIENCES, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001457612, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2022-03-18, it reported annual revenue of USD 1,641,000; net income of USD -33,196,000; total assets of USD 55,967,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $1.6M (USD 1,641,000)
- **Net income:** -$33.2M (USD -33,196,000)
- **Total assets:** $56.0M (USD 55,967,000)
- **Cash and equivalents:** $37.1M (USD 37,148,000)
- **Operating cash flow:** -$45.4M (USD -45,370,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $1.4M (USD 1,359,000)
- **Net income:** -$43.7M (USD -43,714,000)
- **Total assets:** $98.5M (USD 98,493,000)
- **Cash and equivalents:** $79.8M (USD 79,769,000)
- **Operating cash flow:** -$41.7M (USD -41,651,000)

### FY2019 (period ended 2019-12-31)

- **Net income:** -$39.0M (USD -38,950,000)
- **Total assets:** $52.6M (USD 52,611,000)
- **Cash and equivalents:** $40.1M (USD 40,127,000)
- **Operating cash flow:** -$37.7M (USD -37,734,000)

### FY2018 (period ended 2018-12-31)

- **Net income:** -$27.8M (USD -27,811,000)
- **Total assets:** $31.1M (USD 31,115,000)
- **Cash and equivalents:** $26.4M (USD 26,361,000)

## Recent SEC filings

- Form 8-K — filed 2022-06-01 — period 2022-05-25 — 8-K
- Form 8-K — filed 2022-05-24 — period 2022-05-20 — 8-K
- Form 10-Q — filed 2022-05-05 — period 2022-03-31 — 10-Q
- Form 10-K/A — filed 2022-04-29 — period 2021-12-31 — 10-K/A
- Form 8-K — filed 2022-04-28 — period 2022-04-28 — 8-K
- Form 10-K — filed 2022-03-18 — period 2021-12-31 — 10-K
- Form 8-K — filed 2022-03-10 — period 2022-03-10 — 8-K
- Form 8-K — filed 2022-03-07 — period 2022-03-03 — 8-K
- Form 8-K — filed 2022-01-04 — period 2021-12-28 — 8-K
- Form 10-Q — filed 2021-10-28 — period 2021-09-30 — 10-Q
- Form 8-K — filed 2021-10-28 — period 2021-10-28 — 8-K
- Form 8-K — filed 2021-09-13 — period 2021-09-08 — 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/genocea-biosciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology